Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 12.4 Million shares of VRNA, which is worth approximately $1.12 Billion. The most recent transaction as insider was on Jul 08, 2025, when has been sold 90,320 shares (Ordinary Shares) at a price of $11.44 per share, resulting in proceeds of $1,033,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M
6.82% 3M change
16.9% 12M change
Total Value Held $1.12 Billion

Mark W Hahn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2025
SELL
Payment of exercise price or tax liability
$1,033,260 $11.44 p/Share
90,320 Reduced 0.72%
12,418,184 Ordinary Shares
Jul 07 2025
BUY
Exercise of conversion of derivative security
-
229,512 Added 1.8%
12,508,504 Ordinary Shares
Jun 11 2025
SELL
Open market or private sale
$4,560,000 $11.4 p/Share
400,000 Reduced 3.15%
12,278,992 Ordinary Shares
May 29 2025
SELL
Open market or private sale
$1,911,381 $9.33 p/Share
204,864 Reduced 1.59%
12,678,992 Ordinary Shares
May 28 2025
SELL
Open market or private sale
$1,513,147 $9.3 p/Share
162,704 Reduced 1.25%
12,883,856 Ordinary Shares
May 27 2025
SELL
Open market or private sale
$309,076 $9.53 p/Share
32,432 Reduced 0.25%
13,046,560 Ordinary Shares
May 02 2025
SELL
Open market or private sale
$3,636,000 $9.09 p/Share
400,000 Reduced 2.97%
13,078,992 Ordinary Shares
May 01 2025
SELL
Open market or private sale
$1,673,721 $8.95 p/Share
187,008 Reduced 1.37%
13,478,992 Ordinary Shares
May 01 2025
BUY
Exercise of conversion of derivative security
-
200,000 Added 1.45%
13,557,728 Ordinary Shares
Apr 29 2025
SELL
Open market or private sale
$811,432 $8.98 p/Share
90,360 Reduced 0.67%
13,466,000 Ordinary Shares
Apr 29 2025
BUY
Exercise of conversion of derivative security
-
229,512 Added 1.66%
13,556,360 Ordinary Shares
Feb 03 2025
SELL
Payment of exercise price or tax liability
$1,194,918 $7.16 p/Share
166,888 Reduced 1.24%
13,326,848 Ordinary Shares
Feb 01 2025
BUY
Grant, award, or other acquisition
-
200,000 Added 1.46%
13,493,736 Ordinary Shares
Dec 06 2024
SELL
Open market or private sale
$920,477 $5.01 p/Share
183,728 Reduced 1.36%
13,293,736 Ordinary Shares
Dec 05 2024
SELL
Open market or private sale
$3,206,640 $5.01 p/Share
640,048 Reduced 4.53%
13,477,464 Ordinary Shares
Dec 04 2024
SELL
Open market or private sale
$290,920 $5.0 p/Share
58,184 Reduced 0.41%
14,117,512 Ordinary Shares
Dec 02 2024
SELL
Open market or private sale
$8,000 $5.0 p/Share
1,600 Reduced 0.01%
14,175,696 Ordinary Shares
Nov 29 2024
SELL
Open market or private sale
$494,507 $5.01 p/Share
98,704 Reduced 0.69%
14,177,296 Ordinary Shares
Nov 27 2024
SELL
Open market or private sale
$64,680 $5.0 p/Share
12,936 Reduced 0.09%
14,276,000 Ordinary Shares
Nov 26 2024
SELL
Open market or private sale
$4,000 $5.0 p/Share
800 Reduced 0.01%
14,288,936 Ordinary Shares
Nov 25 2024
SELL
Open market or private sale
$8,000 $5.0 p/Share
1,600 Reduced 0.01%
14,289,736 Ordinary Shares
Nov 11 2024
SELL
Open market or private sale
$12,000 $5.0 p/Share
2,400 Reduced 0.02%
14,291,336 Ordinary Shares
Nov 04 2024
SELL
Open market or private sale
$354,641 $4.39 p/Share
80,784 Reduced 0.56%
14,293,736 Ordinary Shares
Nov 01 2024
SELL
Open market or private sale
$214,129 $4.38 p/Share
48,888 Reduced 0.34%
14,374,520 Ordinary Shares
Nov 01 2024
SELL
Payment of exercise price or tax liability
$1,042,836 $4.24 p/Share
245,952 Reduced 1.68%
14,423,408 Ordinary Shares
MWH

Mark W Hahn

Chief Financial Officer
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA